[{"address1": "2223 Avenida de la Playa", "address2": "Suite 208", "city": "La Jolla", "state": "CA", "zip": "92037", "country": "United States", "phone": "619 400 1170", "website": "https://www.gribio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis. The company's portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Dr. W. Marc Hertz Ph.D.", "age": 54, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 617224, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vipin  Kumar Chaturvedi Ph.D.", "age": 65, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 419420, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leanne M. Kelly", "age": 47, "title": "CFO & Corporate Secretary", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 469420, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Albert  Agro Ph.d.", "age": 60, "title": "Co-Founder & Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 461099, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.95, "open": 1.94, "dayLow": 1.8501, "dayHigh": 1.9694, "regularMarketPreviousClose": 1.95, "regularMarketOpen": 1.94, "regularMarketDayLow": 1.8501, "regularMarketDayHigh": 1.9694, "payoutRatio": 0.0, "beta": -1.443, "trailingPE": 0.021365639, "forwardPE": -0.7376426, "volume": 143730, "regularMarketVolume": 143730, "averageVolume": 1197437, "averageVolume10days": 214920, "averageDailyVolume10Day": 214920, "bid": 1.9, "ask": 1.97, "bidSize": 1, "askSize": 1, "marketCap": 4879692, "fiftyTwoWeekLow": 1.1, "fiftyTwoWeekHigh": 30.43, "allTimeHigh": 480807.6, "allTimeLow": 1.1, "fiftyDayAverage": 1.7058, "twoHundredDayAverage": 3.884915, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -146308, "profitMargins": 0.0, "floatShares": 2514827, "sharesOutstanding": 2515305, "sharesShort": 255041, "sharesShortPriorMonth": 50513, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.1014, "heldPercentInsiders": 0.00018999999, "heldPercentInstitutions": 0.014570001, "shortRatio": 0.08, "shortPercentOfFloat": 0.1014, "impliedSharesOutstanding": 2515305, "bookValue": 1.331, "priceToBook": 1.4575508, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -11919000, "trailingEps": 90.8, "forwardEps": -2.63, "lastSplitFactor": "1:17", "lastSplitDate": 1740355200, "enterpriseToEbitda": 0.015, "52WeekChange": -0.9135472, "SandP52WeekChange": 0.13837254, "quoteType": "EQUITY", "currentPrice": 1.94, "targetHighPrice": 35.0, "targetLowPrice": 10.0, "targetMeanPrice": 22.5, "targetMedianPrice": 22.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 5122000, "totalCashPerShare": 2.036, "ebitda": -10027000, "totalDebt": 96000, "quickRatio": 2.218, "currentRatio": 2.415, "debtToEquity": 2.89, "returnOnAssets": -0.98684, "returnOnEquity": -2.48924, "freeCashflow": -5767375, "operatingCashflow": -9169000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GRI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "GRI Bio, Inc.", "postMarketChangePercent": 1.03093, "postMarketPrice": 1.96, "postMarketChange": 0.02, "regularMarketChange": -0.00999999, "regularMarketDayRange": "1.8501 - 1.9694", "earningsTimestampStart": 1755001800, "earningsTimestampEnd": 1755520200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 90.8, "epsForward": -2.63, "epsCurrentYear": -5.86, "priceEpsCurrentYear": -0.33105803, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612967400000, "shortName": "GRI Bio, Inc.", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1197437, "fiftyTwoWeekLowChange": 0.84000003, "fiftyTwoWeekLowChangePercent": 0.76363635, "fiftyTwoWeekRange": "1.1 - 30.43", "fiftyTwoWeekHighChange": -28.49, "fiftyTwoWeekHighChangePercent": -0.9362471, "fiftyTwoWeekChangePercent": -91.35472, "marketState": "CLOSED", "fiftyDayAverageChange": 0.2342, "fiftyDayAverageChangePercent": 0.13729627, "twoHundredDayAverageChange": -1.944915, "twoHundredDayAverageChangePercent": -0.5006326, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "regularMarketChangePercent": -0.51282, "regularMarketPrice": 1.94, "corporateActions": [], "postMarketTime": 1760745392, "regularMarketTime": 1760731201, "exchange": "NCM", "messageBoardId": "finmb_136941170", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "GRI Bio", "trailingPegRatio": null, "__fetch_time": "2025-10-18"}]